Sodium Bicarbonate for Acute Peripheral Vertigo
Peripheral Vertigo
About this trial
This is an interventional treatment trial for Peripheral Vertigo focused on measuring Sodium Bicarbonate, Diphenhydramine
Eligibility Criteria
Inclusion Criteria: Patients with acute onset vertigo Exclusion Criteria: Pregnancy First vertigo episode over 24 hours Using any anti-vertigo medicine after onset Drug allergy to Sodium bicarbonate or Diphenhydramine Diagnosed with central vertigo Heart failure NYHA class >1 Chronic kidney disease (CKD) stage ≥ 3
Sites / Locations
- National Taiwan University Yunlin BranchRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Diphenhydramine
Sodium Bicarbonate
Diphenhydramine with Sodium Bicarbonate
Diphenhydramine 30 mg in 100 mL normal saline intravenous dripping
Sodium bicarbonate 66.4 mEq in 100 mL normal saline intravenous dripping
Diphenhydramine 30 mg in 100 mL normal saline intravenous dripping with Sodium bicarbonate 66.4 mEq intravenous push